Common questions about Lercadip (FAQ)
Q: How quickly does Lercadip typically start to lower blood pressure?
A: According to official product information, the medicine is typically absorbed and reaches its highest level in the blood plasma about 1.5 to 3 hours after a dose. The blood pressure-lowering effect is designed to last for at least 24 hours, which is consistent with its once-daily dosing regimen.
Q: Can Lercadip be taken with food, or does it need to be taken on an empty stomach?
A: Official recommendations advise taking this medicine at least 15 minutes before a meal, preferably breakfast. Taking Lercadip with a high-fat meal can significantly increase the level of the medicine absorbed into the bloodstream. This difference in absorption is why the administration timing is defined in official documents.
Q: Are there any specific dietary restrictions to follow while using Lercadip?
A: Regulatory documents strictly prohibit taking this medicine with grapefruit or grapefruit juice due to the risk of increased medicine levels in the blood. It is also recommended to avoid alcohol consumption during treatment, as it may enhance the blood pressure-lowering effect.
Q: Do studies support Lercadip's use as a combination therapy for high blood pressure?
A: Research evidence has examined Lercadip’s use both alone and in combination with other blood pressure medicines. Official documents indicate that it has been studied alongside treatments such as ACE inhibitors, diuretics, or beta-blockers.
Q: Can people with diabetes safely take Lercadip?
A: Clinical trials for Lercadip have included patients with conditions like Type 2 Diabetes Mellitus. When this medicine is used by individuals with diabetes, official guidance notes that special care and consideration are typically required.
Q: Is the timing of Lercadip administration related to its effectiveness?
A: Yes, official instructions require the medicine to be taken at least 15 minutes before a meal. This timing is important because consuming it with a high-fat meal can significantly alter the amount of medicine absorbed into the bloodstream.
Q: What are some common reasons people stop taking Lercadip?
A: The decision to adjust or stop any treatment is typically made due to insufficient effectiveness or the occurrence of side effects. Commonly reported side effects include headache, ankle swelling, and flushing.
Q: Can Lercadip cause swelling in the ankles or feet?
A: Yes, swelling of the ankles or feet (oedema) is listed in regulatory documents as a commonly reported side effect, potentially affecting up to 1 in 10 people.
Q: Are headaches a common side effect when starting Lercadip?
A: Yes, headaches are one of the most commonly reported side effects. Official product information indicates that headaches may affect up to 1 in 10 people.
Q: Is there a link between Lercadip and feeling dizzy or lightheaded?
A: Feeling dizzy or lightheaded is listed in the official side effect profile. Dizziness is reported as an uncommon side effect, which may affect up to 1 in 100 people.
Q: Does taking Lercadip affect my ability to drive or operate machinery?
A: Regulatory warnings advise against driving or operating machinery if you experience certain side effects. If side effects such as dizziness, weakness, or drowsiness occur, official warnings advise against driving or operating machinery.
Q: Is Lercadip safe to use long-term?
A: Lercadip is typically prescribed for the long-term management of high blood pressure. Clinical trials lasting up to 12 months reported that the blood pressure-lowering effect was maintained and that the development of tolerance was not observed.
Q: Can Lercadip affect the results of blood tests?
A: Regulatory information notes that changes in liver function have been reported. These changes are typically detected by blood tests during routine monitoring.
Q: What happens if I accidentally take two doses of Lercadip close together?
A: Official overdose information indicates that taking more than the prescribed amount may cause an excessive drop in blood pressure. It can also cause the heart rate to increase or become irregular (tachycardia).
Q: Is it normal to feel tired or fatigued after starting Lercadip?
A: Feeling weak or tired is listed as an uncommon side effect in the official product information. This effect may potentially affect up to 1 in 100 people.
Q: What is the difference between Lercadip and other 'dipine' medications?
A: Lercadip is a dihydropyridine calcium channel blocker. Official documents describe its long-lasting effect, high selectivity for blood vessels, and is known for high vascular selectivity, a factor which may relate to the incidence of common side effects like ankle swelling compared to other drugs in the class.
Q: Can older adults generally use Lercadip safely?
A: Clinical studies have examined the use of Lercadip in older adults. Regulatory analysis reported that adverse events in older patients were comparable to those seen in younger adult patient groups.
Q: Is Lercadip suitable for people who have kidney problems?
A: Lercadip is not recommended and is formally contraindicated for people with severe kidney impairment (GFR < 30 ml/min). Special care or cautious dose adjustments may be required when used by those with mild to moderate kidney dysfunction.
Q: What is the safety classification of Lercadip during pregnancy or while breastfeeding?
A: According to official product information, Lercadip is not recommended for use during pregnancy. Furthermore, it should not be used by women who are breastfeeding.
Q: What were the main findings of the clinical trials for Lercadip?
A: Clinical trials primarily documented significant reductions in both systolic and diastolic blood pressure compared to inactive treatment (placebo). The blood pressure-lowering effect was shown to be maintained for 24 hours with once-daily dosing.
Q: Is Lercadip considered a first-line treatment for high blood pressure?
A: Lercadip is officially indicated for the treatment of mild to moderate essential hypertension in adults. The indication reflects the population for which the medicine has been studied and approved by regulatory bodies.
Q: Is it common for people to take Lercadip at night instead of in the morning?
A: Official administration instructions advise taking Lercadip at least 15 minutes before a meal, preferably before breakfast. It is important that any changes to the timing of administration be consistent with medical guidance.
Q: Does Lercadip cause or contribute to heartburn or indigestion?
A: Heartburn and stomach pain are listed as uncommon side effects in the official product information. These effects may potentially affect up to 1 in 100 people.
Q: What are the signs of an allergic reaction to Lercadip?
A: Symptoms of an allergic reaction may include rash, itching, hives, and fainting. More severe signs include swelling of the face, lips, tongue, or throat, which can cause difficulty breathing or swallowing.
Q: Does the effectiveness of Lercadip decrease over time?
A: Clinical trials extending up to 12 months reported that the blood pressure-lowering effect was maintained over the study period. Regulatory reviews noted that the development of tolerance was not observed.
Q: What information is available about Lercadip's impact on sexual health?
A: Regulatory information notes that reversible biochemical changes in sperm, which may potentially impair fecundation, have been reported in some men treated with calcium channel blockers.
Q: Is a low pulse rate an expected effect when using Lercadip?
A: No significant effect on the heart rate was observed in long-term studies of Lercadip. However, an increase in heart rate or palpitations are listed as common side effects.
Q: What is the general duration of action for Lercadip?
A: The blood pressure-lowering effect of Lercadip is designed to last for at least 24 hours. This sustained action supports its once-daily dosing regimen.
Q: Are there different strengths of Lercadip available?
A: Lercadip is typically available in two strengths of film-coated tablets: 10 mg and 20 mg. These strengths are defined in the official product labeling for use in adults.
Q: Does Lercadip interact with alcohol consumption?
A: Yes, regulatory warnings advise avoiding alcohol consumption. Alcohol may enhance, or potentiate, the blood pressure-lowering effect of this medicine.
Q: What are the most commonly reported serious side effects of Lercadip?
A: Serious but rare side effects reported in official documents include angina pectoris (chest tightness), severe allergic reactions, and isolated cases of heart attack. The risk of these events is low.
Q: How is Lercadip elimination from the body described in medical literature?
A: Lercadip is primarily broken down in the liver through metabolism. It is then eliminated from the body, with approximately 50% of the medicine being excreted via the urine.
Q: Do research studies compare Lercadip to lifestyle changes alone?
A: Clinical studies compared Lercadip against an inactive treatment known as a placebo to measure the difference in blood pressure reduction. This comparison helps determine the medicine's independent effect.
Q: Is Lercadip known to cause sleep problems or insomnia?
A: Sleepiness is listed as a rare side effect, potentially affecting up to 1 in 1,000 people. Insomnia (inability to sleep) is not explicitly listed in the official side effect profile.
Q: What kind of patient monitoring (like blood pressure checks) is typical when taking Lercadip?
A: As with all blood pressure medicines, monitoring your blood pressure is typical. This allows your doctor to gradually adjust the dose, typically after two weeks, to determine the maximal blood pressure-lowering effect.
Q: Does Lercadip have an effect on cholesterol levels?
A: Lercadip has been noted in research to have a high tolerance factor for cholesterol. This property is described as potentially beneficial when treating hypertension associated with atherosclerotic disease.
Q: Can Lercadip be taken with antacids?
A: No significant interaction was observed when Lercadip was taken with cimetidine, which is a medicine sometimes used for stomach acid. This observation was made at a specific dose of 800 mg daily, and caution is advised at higher doses.
Q: What is the role of Lercadip in managing isolated systolic hypertension?
A: Lercadip has demonstrated effectiveness in lowering systolic blood pressure in clinical studies. This includes studies specifically involving patients with isolated systolic hypertension.
